What the changes say
- DUKE Robotics faces severe going concern doubts as cash falls short of projected twelve-month operating requirements.
- Operations in Israel expose the company to heightened geopolitical, military, and export control risks from the Israeli Ministry of Defense.
- Revenue concentration on government and energy utility customers creates vulnerability to budget delays and procurement changes.
What changed since the prior 10-K
New
- NewRisks Related to Our Financial Condition and Capital Requirements
We believe our current cash on hand will not be sufficient to fund our projected operating requirements for a period of twelve months from the issuance of these interim financial statements included in this Quarterly Report. This raises substantial doubt about our ability to continue as a going concern
Our current cash on hand is insufficient to fund projected operating requirements for twelve months, creating substantial doubt about our ability to continue as a going concern.
- NewRisks Related to our Business and Industry
Political developments, changes in government policy or international relations and heightened sensitivity around defense, security and critical infrastructure technologies may further restrict our ability to compete for contracts or may subject our products and operations to increased scrutiny
Deploying our products in high-risk or mission-critical applications may expose us to increased litigation risk, product liability claims, and reputational harm.
- NewRisks Related to our Business and Industry
A substantial portion of our expected revenues is subject to Israeli export control regulations, and any failure to obtain or maintain required approvals or licenses could materially and adversely affect our business, results of operations and financial condition
A substantial portion of our expected revenues depends on Elbit obtaining and maintaining export control licenses from the Israeli Ministry of Defense for the Bird of Prey drone systems.
- NewRisks Related to our Common Stock
Because we originally became a public company through a reverse merger, we may continue to face challenges in attracting analyst coverage and institutional investor interest
Becoming a public company through a reverse merger rather than an underwritten IPO may limit analyst coverage, institutional investor interest, and trading volume.
- NewRisks Related to our Common Stock
Sales of a substantial number of shares of our common stock, including shares that may be issued upon the exercise or conversion of outstanding securities or become freely tradable under Rule 144, could cause the market price of our common stock to decline
Sales of a substantial number of our 2,252,151 outstanding shares of common stock under Rule 144 or registration statements could depress our stock price.
- NewRisks Related to our Common Stock
Because we may issue preferred stock without the approval of our shareholders and have other anti-takeover defenses, it may be more difficult for a third party to acquire us and could depress our stock price
Our board of directors may issue preferred stock without shareholder approval, which could create anti-takeover defenses and depress our stock price.
- NewRisks Related to Israeli Law and Our Operations in Israel
Undetected defects or malfunctions in our products could impair our financial results, harm our reputation and expose us to significant product liability claims that may not be adequately covered by insurance
Undetected defects or malfunctions in our complex products could cause severe injuries, property damage, and costly product liability claims not fully covered by insurance.
Dropped
- DroppedRisks Related to our Business and Industry
The sale of our products is subject to various regulatory requirements of the Israeli Ministry of Defense and will also be subject to regulatory requirements in countries in which we seek to sell our products
- DroppedRisks Related to our Common Stock
Sales of our currently issued and outstanding stock may become freely tradable pursuant to Rule 144 and may dilute the market for your shares and have a depressive effect on the price of the shares of our common stock
- DroppedRisks Related to our Common Stock
The securities issued in connection with the Share Exchange are restricted securities and may not be transferred in the absence of registration or the availability of a resale exemption
- DroppedRisks Related to Israeli Law and Our Operations in Israel
Our operations may be disrupted as a result of the obligation of management or key personnel to perform military service
- DroppedRisks Related to Israeli Law and Our Operations in Israel
Undetected problems in our products could impair our financial results and give rise to potential product liability claims
Reworded
- 76% rewrittenRisks Related to Israeli Law and Our Operations in Israel
Our principal executive offices and other significant operations are located in Israel, and, therefore, our results may be adversely affected by political, economic and military instability in Israel, including the 2023 attack by Hamas and other terrorist organizations from the Gaza Strip and Israel’s war against them
Explicitly added references to the 2023 Hamas attack and Israel's ongoing war as operational risks.
Was: Our principal executive offices and other significant operations are located in Israel, and, therefore, our results may be adversely affected by political, economic and military instability in Israel, including the recent attacks by Hamas and other terrorist organizations and Israel’s war against them
- 74% rewrittenRisks Related to our Business and Industry
Our revenues will depend heavily on government contracts
Expanded revenue sources to include civilian sectors alongside energy utility customers and detailed government budgeting uncertainties.
- 71% rewrittenRisks Related to our Business and Industry
We may experience production delays if suppliers fail to make compliant or timely deliveries
Added specific supply chain risks regarding limited availability of electronics, sensors, batteries, and semiconductors.
- 44% rewrittenRisks Related to our Business and Industry
We were granted a patent for certain of our key technologies and may apply for additional patents in the future. Our ability to protect our intellectual property and proprietary technology is uncertain and may be inadequate, which may have a material and adverse effect on us
Clarified that competitors may obtain proprietary rights to technologies or processes rather than just compounds.
- 41% rewrittenRisks Related to our Business and Industry
We may become subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from developing our products, require us to obtain licenses from third parties or to develop non-infringing alternatives and subject us to substantial monetary damages
Maintained core substance regarding potential third-party intellectual property infringement claims with minor stylistic adjustments.
- 20% rewrittenRisks Related to Israeli Law and Our Operations in Israel
Our operations are subject to currency and interest rate fluctuations
Added the Euro as a currency alongside U.S. dollars and NIS affecting foreign exchange fluctuations and expenses.
All 36 risk factors
Headings as the filing states them, in filing order.
Risks Related to Our Financial Condition and Capital Requirements
- 01We believe our current cash on hand will not be sufficient to fund our projected operating requirements for a period of twelve months from the issuance of these interim financial statements included in this Quarterly Report. This raises substantial doubt about our ability to continue as a going concernNew
Risks Related to our Business and Industry
- 02We have a limited operating history and have generated limited revenues to date
- 03We may not be able to obtain adequate financing to continue our operations
- 04We have inadequate capital and need for additional financing to accomplish our business and strategic plans. Terms of subsequent financing, if any, may adversely impact your investment
- 05Our revenues will depend heavily on government contracts74% rewritten
- 06Political developments, changes in government policy or international relations and heightened sensitivity around defense, security and critical infrastructure technologies may further restrict our ability to compete for contracts or may subject our products and operations to increased scrutinyNew
- 07A substantial portion of our expected revenues is subject to Israeli export control regulations, and any failure to obtain or maintain required approvals or licenses could materially and adversely affect our business, results of operations and financial conditionNew
- 08We face other risks in our expected international sales
- 09We may experience production delays if suppliers fail to make compliant or timely deliveries 71% rewritten
- 10If we fail to manage growth or to prepare for product scalability effectively, it could have an adverse effect on our employee efficiency, product quality, working capital levels and results of operations
- 11We were granted a patent for certain of our key technologies and may apply for additional patents in the future. Our ability to protect our intellectual property and proprietary technology is uncertain and may be inadequate, which may have a material and adverse effect on us44% rewritten
- 12We may become subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from developing our products, require us to obtain licenses from third parties or to develop non-infringing alternatives and subject us to substantial monetary damages41% rewritten
Risks Related to our Common Stock
- 13Our executive officer, directors and certain stockholders who are beneficial owners of more than 5% of our outstanding common shares possess the majority of our voting power, and through this ownership, have the ability to control our Company and our corporate actions
- 14Because we originally became a public company through a reverse merger, we may continue to face challenges in attracting analyst coverage and institutional investor interestNew
- 15There is a substantial lack of liquidity of our common stock and volatility risks
- 16Because we became public by means of a “reverse merger,” we may not be able to attract the attention of major brokerage firms
- 17Our common stock may never be listed on a major stock exchange
- 18Sales of a substantial number of shares of our common stock, including shares that may be issued upon the exercise or conversion of outstanding securities or become freely tradable under Rule 144, could cause the market price of our common stock to declineNew
- 19Our common stock is subject to price volatility unrelated to us or our operations
- 20We do not plan to declare or pay any dividends to our stockholders in the near future
- 21“Penny Stock” rules may make buying or selling our common stock difficult
- 22The sales practice requirements of FINRA may also limit a stockholder’s ability to buy and sell our stock
- 23Because we may issue preferred stock without the approval of our shareholders and have other anti-takeover defenses, it may be more difficult for a third party to acquire us and could depress our stock priceNew
Risks Related to Israeli Law and Our Operations in Israel
- 24Our principal executive offices and other significant operations are located in Israel, and, therefore, our results may be adversely affected by political, economic and military instability in Israel, including the 2023 attack by Hamas and other terrorist organizations from the Gaza Strip and Israel’s war against them76% rewritten
- 25Our operations are subject to currency and interest rate fluctuations20% rewritten
- 26It may be difficult to enforce a judgment of a United States court against us and our officers and directors to assert United States securities laws claims in Israel or to serve process on our officers and directors and these experts
- 27We operate in a competitive industry
- 28Undetected defects or malfunctions in our products could impair our financial results, harm our reputation and expose us to significant product liability claims that may not be adequately covered by insuranceNew
- 29Our business depends on proprietary technology that may be infringed
- 30Potential product liability claims could adversely affect our future earnings and financial condition
- 31We rely on highly skilled personnel and, if we are unable to retain or motivate key personnel or hire additional qualified personnel, we may not be able to grow effectively
- 32Our management team may not be able to successfully implement our business strategies
- 33Significant disruptions of our information technology systems or breaches of our data security could adversely affect our business
- 34A decline in the price of our common stock could affect our ability to raise working capital and adversely impact our ability to continue operations
- 35The requirements of being a public company may strain our resources and distract management
- 36Future changes in financial accounting standards or practices may cause adverse unexpected financial reporting fluctuations and affect reported results of operations
Other DUKE Robotics 10-Ks
- FY2024 10-K risk factors34 risks
DUKE Robotics operates with minimal staff and capital, facing heavy reliance on Israeli operations and military conflict risks, plus government contracts for drone technology.
Filed Mar 20, 2025
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.